ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Different Stakeholder Perspectives On Navigating DHT Guidance

  In a recent panel, industry leaders discussed the implications of FDA guidance for sponsors and developers implementing DHT as an innovative way to capture multidimensional patient data remotely.

• Navigating Biases In Clinical Trial Vendor Selection

  Biases, often hidden, can distort vendor selection decisions. Recognizing and addressing them across individuals and teams leads to more objective, aligned, and successful clinical trial outcomes.

• The Vendor Selection Blunder: An Expensive Oversight In Clinical Trials

  Vendor selection isn’t just procedural — it shapes trial outcomes. Even with a solid process, missteps can ripple through timelines, budgets, and team morale. Choose wisely.

• What Everest Group's RTSM Recognition Means For The Industry

  RTSM is transforming from a basic operational tool into a strategic driver of trial efficiency. Learn why industry recognition signals a new era of innovation and competitive advantage.

• Empowering Oncology Research With The Right Technology Solutions

  Explore how advanced technology solutions have the potential to simplify the operational aspects of oncology trials.

• Moving Towards AI, ML, And Trial Platforms For True Scalability

  Uncover why AI, ML, and clinical trial platforms have the potential to create true scalability across an organization's entire pipeline, and reduce timelines by YEARS.

• Leveraging The Window Of Opportunity In Clinical Trial Recruitment

  Access to real-world data now makes it possible to identify potential trial participants, wherever they are.

• Parkinson's Disease: Leveraging Wearable DHTs

  Wearable DHTs offer a solution to the challenges of measuring Parkinson's disease in clinical trials. Discover how these technologies can improve outcome measures and accelerate drug development.

• Site And Sponsor Harmonization For Speedy Startups, Monitoring

  Now more than ever, stakeholders need harmony among their disparate systems — and that starts with the right organizational mindset: a culture of connectivity. Here’s what our experts recommend.

• A Custom IRT System Facilitates Precision Medicine Studies

  As the industry continues to embrace personalized medicine, the ability to implement and support an atypical supply chain is crucial.